
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MiRP1 CRISPR/Cas9 KO Plasmid (h) | sc-418462 | 20 µg | $397.00 |
KCNE2 encodes the human MinK-related peptide 1 (MiRP1), a single-pass transmembrane β-subunit that modulates voltage-gated potassium channel function, including KCNH2/hERG, to tune channel gating, trafficking, and membrane repolarization. Through its effects on cardiac action potential duration and epithelial ion transport, MiRP1 contributes to electrical excitability and electrolyte homeostasis in tissues such as heart and gastrointestinal epithelium. Perturbation of KCNE2-dependent channel regulation is linked to altered repolarization reserve and arrhythmia susceptibility, and has also been studied in relation to thyroid and gastric physiology. As a modulatory subunit, MiRP1 provides a mechanistic entry point for dissecting ion channel macromolecular complexes, membrane protein quality control, and stimulus-dependent changes in excitability.
MiRP1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the KCNE2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the KCNE2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the KCNE2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MiRP1 protein expression.
This CRISPR knockout system enables efficient generation of KCNE2-deficient cell models for investigation of MiRP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.